Deferred Tax Assets, Valuation Allowance of ESCALON MEDICAL CORP from 30 Jun 2011 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ESCALON MEDICAL CORP quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Jun 2011 to 30 Jun 2025.
  • ESCALON MEDICAL CORP Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Jun 2025 was $7,073,376, a 7% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

ESCALON MEDICAL CORP Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $7,073,376 -$534,389 -7% 30 Jun 2025 10-K 29 Sep 2025 2025 FY
Q2 2024 $7,607,765 +$53,359 +0.71% 30 Jun 2024 10-K 29 Sep 2025 2025 FY
Q2 2023 $7,554,406 -$95,065 -1.2% 30 Jun 2023 10-K 30 Sep 2024 2024 FY
Q2 2022 $7,649,471 +$106,220 +1.4% 30 Jun 2022 10-K 13 Oct 2023 2023 FY
Q2 2021 $7,543,251 -$66,042 -0.87% 30 Jun 2021 10-K 28 Sep 2022 2022 FY
Q2 2020 $7,609,293 -$10,364 -0.14% 30 Jun 2020 10-K 27 Sep 2021 2021 FY
Q2 2019 $7,619,657 +$56,941 +0.75% 30 Jun 2019 10-K 28 Sep 2020 2020 FY
Q2 2018 $7,562,716 -$4,498,115 -37% 30 Jun 2018 10-K 27 Sep 2019 2019 FY
Q2 2017 $12,060,831 +$147,610 +1.2% 30 Jun 2017 10-K 28 Sep 2018 2018 FY
Q2 2016 $11,913,221 +$283,825 +2.4% 30 Jun 2016 10-K 28 Sep 2017 2017 FY
Q2 2015 $11,629,396 +$215,109 +1.9% 30 Jun 2015 10-K 12 Oct 2016 2016 FY
Q2 2014 $11,414,287 -$232,610 -2% 30 Jun 2014 10-K 29 Sep 2015 2014 FY
Q2 2013 $11,646,897 -$716,879 -5.8% 30 Jun 2013 10-K 26 Sep 2014 2014 FY
Q2 2012 $12,363,776 +$517,933 +4.4% 30 Jun 2012 10-K 20 Sep 2013 2013 FY
Q2 2011 $11,845,843 30 Jun 2011 10-K 26 Sep 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.